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ABSTRACT
To compare the preventive treatment benefits of amitriptyline and aerobic exercise or amitriptyline alone in patients with chronic migraine.
Method: Sixty patients, both genders, aged between 18 and 50 years, with a diagnosis of chronic migraine, were randomized in groups
called amitriptyline and aerobic exercise or amitriptyline alone. The following parameters were evaluated: headache frequency, intensity
and duration of headache, days of the analgesic medication use, body mass index (BMI), Beck Depression Inventory (BDI) and Beck Anxiety
Inventory (BAI) scores. Results: In the evaluated parameters, was observed decrease in headache frequency (p=0.001), moderate intensity
(p=0.048), in headache duration (p=0.001), the body mass index (p=0.001), Beck Depression Inventory (p=0.001) and Beck Anxiety Inventory
scores (p=0.001), when groups were compared in the end of third month. Conclusion: In this study, the amitriptyline was an effective
treatment for chronic migraine, but its efficacy was increased when combined with aerobic exercise.
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RESUMO
Comparar os benefícios do tratamento preventivo em pacientes com migrânea crônica utilizando a amitriptilina associada ao exercício
aeróbico ou amitriptilina isolada. Método: Sessenta pacientes de ambos os sexos com idade entre 18 e 50 anos e com diagnóstico de
migrânea crônica foram randomizados para receber amitriptilina e orientados a: praticar exercícios aeróbicos ou somente a amitriptilina
isolada. Os seguintes parâmetros foram avaliados: frequência, intensidade e duração da cefaleia, dias de uso de medicação analgésica,
índice de massa corporal (IMC), e pontuação nas escalas de Beck Depression Inventory (BDI) e Beck Anxiety Inventory (BAI). Resultados:
Nos parâmetros avaliados, houve redução na frequência da cefaleia (p=0,001), intensidade moderada (p=0,048), na duração (p=0,001), no
índice de massa corporal (p=0,001), e pontuação nas escalas Beck Depression Inventory (p=0,001) e Beck Anxiety Inventory (p=0,001),
quando os grupos foram comparados ao final do terceiro mês. Conclusão: A amitriptilina foi um tratamento eficaz para a migrânea
crônica, mas sua eficácia foi maior quando combinada com exercício aeróbio.
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Chronic migraine is a disabling disease, with a negative
impact on the individual’s ability to perform daily activities1
affecting 2% to 3% of the general population2 and with the
prevalence in Brazilian population of 5%3.
The quality of life in patients with chronic migraine have
significant impairments compared to the healthy population
and also when compared to other chronic conditions4, and
85% of these patients have disabling attacks, justifying the
introduction of prophylactic treatment5.
In episodic migraines, amitriptyline has been used as pro-
phylactic therapy in the last 45 years, and is generally
accepted as an effective drug6.
In addition to reducing the frequency, duration and
intensity of headache attacks, therapy with amitriptyline
may improve the response to acute treatment, reduce dis-
ability, and reduce associated economic costs7,8.
The use of amitriptyline for treatment of migraine
resulted in 50% reduction in the headache frequency.
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Studies demonstrated reduction in headache intensity
and frequency of amitriptyline group compared to the group
venlafaxine9, reduction in the frequency and duration of
headache compared to placebo7. Others studies observed
similar results10,11.
A significant reduction in the use of analgesic medication
was related after prophylaxis with topiramate (50-100 mg/day)
associated with amitriptyline (10-20 mg/day) in migraneurs
with overuse of analgesic medicines12 .
The use of amitriptyline for treatment of migraine
requires initial doses of 10 to 25 mg, and the effective thera-
peutic dose ranges from 25 to 200 mg13.
Studies with amitriptyline demonstrate limited evidence
that the treatment may be beneficial for patients with
chronic migraine14.
Although several studies addressing prophylactic treat-
ment for episodic migraine6,7,8,9,10,11,12,13,14, only topiramate15
and the botulinum toxin16 were effective in placebo-con-
trolled studies for the prophylactic treatment of patients
with chronic migraine.
In addition to the prophylactic drug therapies, multiple
studies have shown benefits of non-pharmacological inter-
ventions such as aerobic exercise17,18,19,20,21,22,23,24. Exercise of
moderate intensity and practiced regularly can promotes
muscle relaxation, improved cardiovascular fitness and also
reduces the frequency, intensity and duration of headache
attacks19.
Hypotheses for the mechanisms by which exercise may
reduce headache include decreased peripheral sensitization
and activation of descending inhibitory pathways25.
Studies where the exercise was supervised by a physical
therapist demonstrated higher patient compliance18,19,20.
However, even the studies without supervision, with exer-
cises performed at home, positive results have been
reported20,21. Despite of positive findings, these studies
showed some limitations as a lack of control groups and
subjective endpoints.
The aim of this study was to compare the combination of
amitriptyline and aerobic exercise with amitriptyline alone
in the prophylactic treatment of patients with chronic
migraine, in a randomized controlled open label trial. The
following parameters were evaluated: headache frequency,
intensity and duration of headache, days of the analgesic
medication use, body mass index (BMI), Beck Depression
Inventory (BDI) and Beck Anxiety Inventory (BAI) scores.
METHOD
Over a 2-year period (June 2010 through June 2012),
patients newly admitted to the out-patient Division of
Investigation and Treatment of Headaches (DITH) of the
Universidade Federal de São Paulo (Unifesp), both genders,
aged between 18 and 50 years, all diagnosed with chronic
migraine by the criteria of “The International Classification
of Headache Disorders (ICHD-II, 2004)”26, were included
in the studies.
Inclusion criteria: patients diagnosed with chronic
migraine, normal cardiac and neurological examination,
who had not been practicing exercise for at least 3 months.
Exclusion criteria: previous use in the last year of medica-
tion with action in the central nervous system, including
migraine prophylactics, other systemic, neurological and
psychiatric disorders, inability to understand verbal com-
mands and to perform aerobic exercise, not treatment com-
pliance during the study.
In neurological evaluation, patients with medication
overuse were instructed to perform a washout of all analgesic
medicines and an abortive therapy with naproxen sodium
550 mg maximum twice a week and non-pharmacological
practices were oriented. In psychological evaluation, patients
were instructed to fill out Beck Depression Inventory and Beck
Anxiety Inventory. After neurological and psychological evalu-
ation patients were simple randomized, using computer-
generated random numbers, in two groups:
N Amitriptyline alone: patients using amitriptyline
(25 mg/day);
N Amitriptyline and aerobic exercise: patients using ami-
triptyline (25 mg/day) combined with aerobic exercise.
In the aerobic exercise program patients were instructed
to perform a 40 minutes fast walk outdoors with a frequency
of 3 times/week for 12 consecutive weeks27 and daily, fill
out a headache questionnaire. All patients received
written instructions and performed a training session with
physiotherapist.
Instruments used in the amitriptyline group and aerobic
exercise: headache questionnaire, explanatory leaflet about
the warm-up exercises, spreadsheet with hours of exercise
performance, Borg scale28 and measurement of heart rate
on the initial and final walk.
Instruments used in the amitriptyline group alone: head-
ache questionnaire.
The following parameters were evaluated: headache fre-
quency (days/month), headache intensity 1 (mild), 2 (mod-
erate) and 3 (disabling), duration/day of headache (6h,
12h, 18h e 24h), analgesic medication use (days/month),
body mass index, Beck Depression Inventory and Beck
Anxiety Inventory at baseline and in the end of the 3rd month.
Also the patients were weekly assessed by telephone calls
and informed the study authors about the evolution of pro-
posed therapies.
The study was submitted and approved by the local Ethic
Committee in Research, and all participants signed an
informed consent form, but they were able to leave the study
anytime and for any reason.
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Statistical analysis
For statistical analysis, Student’s t-test was used. The sig-
nificance level was p#0.05. The Minitab was Statistical
Software utilized.
RESULTS
Sixty patients were randomized for the study, 30 in ami-
triptyline alone group and 30 amitriptyline and aerobic exer-
cise group.
In amitriptyline alone group 4 withdrew from the study
for not using the medication correctly or not could tolerate
the medication side effects (drowsiness and dry mouth) and
in amitriptyline and aerobic exercise group 6 withdrew for
non-adherence to proposed physical treatment.
The comparison of mean age, gender, and onset time of
migraine between the groups were shown in Table 1.
Fifty patients reached the end of study. In the evaluated
parameters, was observed decrease in headache frequency
(p=0.001), duration of headache attacks (p=0.001) intensity
moderate (p=0.048), the body mass index (p=0.006), Beck
Depression Inventory (p=0.001) and Beck Anxiety Inventory
scores (p=0.001) between the groups amitriptyline alone
(n=26) and amitriptyline and aerobic exercise group
(n=24), as summarized on Table 2.
DISCUSSION
This study showed that the combination of a prophylactic
drug therapy amitriptyline with a non-pharmacological treat-
ment aerobic exercise was effective as a preventive therapy
as compared with amitriptyline alone.
There is no consensus in the literature about how
patients with chronic migraine should be instructed to
Table 1. Patients in amitriptyline alone (n=30) and amitriptyline and aerobic exercise group (n=30) according to the average
age, gender and average onset migraine.
Variable Group Amitr alone±SD Group Amitr and exer±SD p-value
Average age (y)±SD 35±8 31±9 0.170
Gender (%) – F:M 88:12 79:21 0.370
Average onset of migraine (y)±SD 17±10 13±11 0.189
Table 2. Results of headache frequency (days/month), duration and intensity of headache attacks (attacks/month), use of
analgesic medication (days/month), body mass index (BMI), Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI)
scores at baseline and the end of the 3rd month in amitriptyline alone (n=26) and amitriptyline and aerobic exercise group
(n=24).
Variable Evaluation Group Amitr alone±SD Group Amitr and exer±SD p-value
Frequency initial 25±6.31 23±6.11
3rd month 13±6.41 5±2.21 0.001**
Duration (6h) initial 1±3.14 4±9.74
3rd month 4±2.94 3±1.79 0.017*
Duration (12h) initial 13±7.50 3±12.1
3rd month 1±4.62 6±1.74 0.001**
Duration (18h) initial 5±9.13 2±3.26
3rd month 3±2.53 1±1.02 0.733
Duration (24h) initial 20±13.9 20±11.0
3rd month 3±6.19 0 0.001**
Intensity 1 (mild) initial 10±8.68 8±8.38
3rd month 5±3.18 3±2.16 0.528
Intensity 2 (moderate) initial 13±6.89 14±7.57
3rd month 6±4.75 3±1.86 0.048*
Intensity 3 (disabling) initial 6±5.50 6±6.55
3rd month 2±2.65 0 0.093
Analgesic Medication initial 20±9.63 16±8.95
3rd month 3±2.99 1±1.48 0.752
BMI initial 24±2.66 24±2.57
3rd month 25±2.92 23±2.64 0.006**
BDI initial 14±11.45 10±6.70
3rd month 10±11.20 6±5.69 0.001**
BAI initial 16±15.85 15±8.91
3rd month 10±12.10 8±7.17 0.001**
*p-value=0.05; **p-value=0.001.
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perform aerobic exercise19, so the parameters of intensity,
frequency and duration of exercise were based on the para-
meters used for the healthy population27.
The regular practice of aerobic exercise seems to benefit
patients with migraine17,18,19,20,21,22,23,24. These benefits could
be related to increased production of beta-endorphins18 or
changes in levels of nitric oxide during aerobic exercise17.
Controlled studies are needed to define the optimal fre-
quency and intensity of exercise20.
Studies showed difference in pain intensity between
groups19,24 and this study also showed a significant reduction
in these evaluated groups.
Despite of findings of decreased intensity, duration and
frequency of headache in physically active people, there
are few studies about the real influence of exercise in
patients with headache21.
Many patients with chronic migraine report that exercise
exacerbates their headaches20. However, in this study was
not observed worsening of headache in chronic migraine
patients.
Obesity is a risk factor to migraine chronicity29. Despite
the weight gain, the amitriptyline group alone had a reduced
frequency of headache attacks. The combination of amitrip-
tyline and aerobic exercise resulted in no increase in body
mass index, therefore, in addition to resulting in greater
efficacy of headache prevention, exercise can also prevent
the adverse effect of weight gain associated with the use
of amitriptyline.
This study had some limitations such as the small sam-
ples of patients evaluated, the aerobic exercise have been
done by patients without supervision. However other studies
without supervision and with the exercises performed at
home led to similar results18,19,20,21.
In conclusion, the therapy with amitriptyline was effect-
ive as a prophylactic treatment for patients with chronic
migraine, however the combination of amitriptyline and
aerobic exercise resulted in an even greater reduction in
the frequency, duration and intensity of headache, in body
mass index, Beck Depression Inventory and Beck Anxiety
Inventory scores.
References
1. Diener H-C, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein
SD. Chronic migraine: classification, characteristics and treatment.
Nat Rev Neurol. 2012;8(3):162-71. http://dx.doi.org/10.1038/nrneurol.
2012.13
2. Aurora SK, Kulthia A, Barrodale PM. Mechanism of chronic migraine.
Curr Pain Headache Rep. 2011;15(1):57-63. http://dx.doi.org/10.1007/
s11916-010-0165-z
3. Queiroz LP, Peres MFP, Kowacs F, Piovesan EJ, Ciciarelli MC, Souza JA
et al. Chronic daily headache in Brazil: a nationwide population-based
study. Cephalalgia. 2008;28(12):1264-9. http://dx.doi.org/10.1111/
j.1468-2982.2008.01670.x
4. Mercante JPP, Bernik MA, Zukerman-Guendler V, Zukerman E,
Kuczynski E, Peres F. Comorbidade psiquiátrica diminui a
qualidade de vida de pacientes com enxaqueca crônica. Arq
Neuropsiquiatr. 2007;65(3B):880-4. http://dx.doi.org/10.1590/s0004-
282x2007000500031
5. Bordini CA. Tratamento profilático. In: Speciali JG, Silva WF, editores.
Cefaléias. São Paulo: Lemos; 2002. p. 90-101.
6. Silberstein SD, Goadsby PJ. Migraine: preventive treatment.
Cephalalgia. 2002;22(7):491-512. http://dx.doi.org/10.1046/j.1468-
2982.2002.00386.x
7. Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam
Physician. 2006;73(1):72-8.
8. Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis.
Changes in pattern of attacks during a controlled clinical trial. J
Neurol Neurosurg Psychiatry. 1973;36(4):684-90. http://dx.doi.org/
10.1136/jnnp.36.4.684
9. Bulut S, Berilgen MS, Baran A, Tekatas A, Atmaca M, Mungen B.
Venlafaxine versus amitriptyline in the prophylactic treatment of
migraine: randomized, double-blind, crossover study. Clin Neurol
Neurosurg. 2004;107(1):44-8. http://dx.doi.org/10.1016/j.clineuro.
2004.03.004
10. Smitherman TA, Walters AB, Maizels M, Penzien DB. The use of
antidepressants for headache prophylaxis. CNS Neurosci Ther.
2011;17(5):462-9. http://dx.doi.org/10.1111/j.1755-5949.2010.00170.x
11. Couch JR. Amitriptyline in the prophylactic treatment of migraine and
chronic daily. Headache. 2011;51(1):33-51. http://dx.doi.org/10.1111/
j.1526-4610.2010.01800.x
12. Valguarnera F, Tanganelli P. The efficacy of withdrawal therapy in
subjects with chronic daily headache and medication overuse
following prophylaxis with topiramate and amitriptyline. Neurol Sci.
2010;31(1 Suppl):S175-7. http://dx.doi.org/10.1007/s10072-010-0319-0
13. Silberstein SD. Preventive migraine treatment. Neurol Clin.
2009;27(2):429-43. http://dx.doi.org/10.1016/j.ncl.2008.11.007
14. Straube A, Gaul C, Förderreuther S, Kropp P, Marziniak M, Evers S
et al. Therapy and care of patients with chronic migraine. Nervenarzt.
2012;83(12):1600-8. http://dx.doi.org/10.1007/s00115-012-3680-9
15. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N,
Mathew N et al. Efficacy and safety of topiramate for the treatment
of chronic migraine: a randomized, double-blind, placebo-controlled
trial. Headache. 2007;47(2):170-80. http://dx.doi.org/10.1111/j.1526-
4610.2006.00684.x
16. Diener HC, Dodick DW, Aurora SK, Turkel C, DeGryse R, Lipton R et al.
OnabotulinumtoxinA for treatment of chronic migraine: results from
the double-blind, randomized, placebo-controlled phase of the
PREEMPT 2 trial. Cephalalgia. 2010;30(7):804-14. http://dx.doi.org/
10.1177/0333102410364677
17. Narin SO, Pinar L, Erbas D, Oztürk V, Idman F. The effects of exercise
and exercise-related changes in blood nitric oxide level on migraine
headache. Clin Rehabil. 2003;17(6):624-30. http://dx.doi.org/10.1191/
0269215503cr657oa
18. Köseoglu E, Akboyraz A, Soyuer A, Ersoy AO. Aerobic exercise and
plasma beta endorphin levels in patients with migrainous headache
without aura. Cephalalgia. 2003;23(10):972-6. http://dx.doi.org/
10.1046/j.1468-2982.2003.00624.x
19. Donna-Marie C, Lockett MA, Campbell JF. The effects of aerobic
exercise on migraine. Headache. 1992;32(1):50-4. http://dx.doi.org/
10.1111/j.1526-4610.1992.hed3201050.x
20. Varkey E, Sider A, Carlsson J, Linde M. A study to evaluate the
feasibility of an aerobic exercise program in patients with migraine.
854 Arq Neuropsiquiatr 2014;72(11):851-855
Headache. 2009;49(4):563-70. http://dx.doi.org/10.1111/j.1526-4610.
2008.01231.x
21. Busch V, Gaul C. Exercise in migraine therapy: is there any evidence
for efficacy? A critical review. Headache. 2008;48(6):890-9. http://dx.
doi.org/10.1111/j.1526-4610.2007.01045.x
22. Domingues RB, Teixeira AL, Domingues SA. Physical practice is
associated with functional disability in medical students with
migraine. Arq Neuropsiquiatr. 2011;69(1):39-43. http://dx.doi.org/
10.1590/s0004-282x2011000100009
23. Darabaneanu S, Overath CH, Rubin D, Luthje S, Sye W, Niederberger
U et al. Aerobic exercise as a therapy option for migraine: a pilot
study. Int J Sports Med. 2011;32(6):455-560. http://dx.doi.org/
10.1055/s-0030-1269928
24. Dittrich SM, Gunther V, Franz G, Burtscher M, Holzner B, Kopp
M. Aerobic exercise with relaxation: influence on pain and psycho-
logical well-being in female migraine patients. Clin J Sport Med.
2008;18(4):363-5. http://dx.doi.org/10.1097/JSM.0b013e31817efac9
25. Fernandes-de-las-Peñas C. Physical therapy and exercise in head-
ache. Cephalalgia. 2008;28(1 Suppl):S36-8. http://dx.doi.org/10.1111/
j.1468-2982.2008.01618.x
26. Headache Classification Subcomitte of the Internacional Headache
Society. The international classification of headache disorders.
Cephalalgia. 2004;24(Suppl s1):36-9. http://dx.doi.org/10.1111/
j.1468-2982.2003.00824.x
27. American College of Sports and Medicine. ACM’s Guideline for
exercise testing and prescription. 7th ed. Baltimore: Lippincott
Willians and Wilkins; 2006.
28. Borg GVA, Noble BJ. Perceived exertion. In: JN Wilmore, editor.
Exercise and sport sciences reviews. New York: Academic Press;
1974.
29. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and
chronic migraine: possible mechanisms of interaction. Neurology.
2007;68(21):1851-61. http://dx.doi.org/10.1212/01.wnl.0000262045.
11646.b1
Michelle Dias Santos Santiago et al. Amitriptyline and aerobic exercise in migraine 855
